Elucid, an AI medical technology company focused on providing physicians with a more precise view of atherosclerosis to drive ...
The appointments have been made as Elucid continues preparations for the commercial launch of its FDA-cleared ... vessel and lesion-level plaque composition and quantification and offers potential ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results